Stem cell therapy for recovery after stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a patient's own bone marrow stem cells, given through a vein, can help improve recovery after a stroke. It is for people who had a moderate stroke 3 to 12 months ago and still have some disability.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You had a moderate stroke 3 to 12 months ago.
- You have some disability from the stroke (for example, needing help with daily activities).
- You are not currently taking blood thinners or immunosuppressive drugs.
- You do not have serious heart, liver, kidney, or other major health problems.
- You have not had cancer or a severe infection like HIV or hepatitis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special type of stem cell (from umbilical cord) can help people recover after a recent ischemic stroke. It aims to see if this treatment can improve movement and reduce disability.
This trial tests whether a nasal spray made from stem cell particles can help people recover after an ischemic stroke. It is for adults who had a stroke within the last two weeks and did not receive clot-busting treatment.
This study tests a combination of proteins from stem cells and a safe brain stimulation method to help people recover movement after a stroke. It may improve recovery when started 1 to 6 months after a first stroke.
This trial tests whether a patient's own stem cells can be safely injected into the brain to help recovery after a stroke. It is for people who had an ischemic stroke 6 months to 5 years ago and still have moderate to severe symptoms.
This trial is testing a new treatment using stem cells from donated umbilical cord tissue to help people recover from a recent moderate to severe stroke. It is for patients who cannot receive standard clot-busting treatments.
This trial tests whether a single infusion of umbilical cord stem cells can help people recover from a recent ischemic stroke (stroke caused by a clot). It is for patients who have had their stroke within the last 72 hours and have moderate to severe symptoms.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.